Uncategorized
Six biomedical Ph.D. students awarded prestigious NSF Graduate Research Fellowships
May. 10, 2022—By Emily Overway The National Science Foundation Graduate Research Fellowship Program is a highly competitive program that awards grants annually. Fellows doing research in NSF-supported areas within science, technology, engineering, or mathematics receive a three-year annual stipend of $34,000, as well as a $12,000 allowance for tuition and fees. Approximately 2,200 fellows are selected each...
Melanoma treatment response
Feb. 25, 2022—Although targeted therapies have been developed for melanoma patients, tumor progression eventually results. Understanding characteristics of melanoma associated with treatment resistance is important for prolonging therapy effectiveness. In a retrospective study of patients treated with BRAF and/or MEK inhibitors, Chi Yan, PhD, Ann Richmond, PhD, and colleagues discovered an association between tumor progression and an...
Monteggia appointed co-editor for Neuropsychopharmacology
Feb. 8, 2022—By Aaron Conley Barlow Family Director of the Vanderbilt Brain Institute and acclaimed neuroscientist Lisa Monteggia was named incoming co-principal editor, along with Dr. Tony George from the University of Toronto, of the journal Neuropsychopharmacology. Their appointments begin in January 2023. According to an NPP release, “Drs. George and Monteggia bring significant expertise in clinical...
Christopher Wright receives 2022 Viktor Hamburger Outstanding Educator Prize
Jan. 21, 2022—Christopher V. Wright. Professor of Cell and Developmental Biology, is the 2022 Viktor Hamburger Outstanding Educator Prize winner. The award honors individuals who have made outstanding and innovative contributions to teaching and learning. Dr. Wright will deliver a named lecture at the SDB Annual Meeting, and will be presented with an Award with Viktor Hamburger’s image.
New Awards Announced for Postdoctoral Scholars in Biochemistry
Jan. 10, 2022—By Dave Cortez and Aaron Conley The Department of Biochemistry at Vanderbilt University School of Medicine Basic Sciences announced new annual awards for postdoctoral scholars called the Destination Biochemistry Postdoctoral Scholar Awards. These awards will support exceptional postdoctoral fellows from around the world as they join labs in the Department of Biochemistry, making it a...
An inward look into Biochemistry
Jan. 6, 2022—By Wendy Bindeman Welcome to the first of four articles in our new “Meet the Departments” series! The Vanderbilt University School of Medicine Basic Sciences is composed of four departments: Biochemistry, Cell and Developmental Biology, Molecular Physiology and Biophysics, and Pharmacology. Through this article series, we will be featuring each one, highlighting their proudest accomplishments,...
In memory of Zach Jones
Sep. 24, 2021—By Mariana Byndloss If I could define Zach in one word, it would be LIGHT. Zach brought LIGHT to the world around him with his kindness, open mind and his way of accepting others and always seeing the good in people. And the funniest thing about it is that I don’t think he realized how...
Basic Sciences welcomes new IMSD leadership
Aug. 25, 2021—By Wendy Bindeman Vanderbilt School of Medicine Basic Sciences is excited to welcome the incoming leadership team for the Initiative for Maximizing Student Diversity. IMSD recruits and supports biomedical trainees from backgrounds underrepresented in science during their graduate careers. The program was founded in 1998 by Roger Chalkley, formerly senior associate dean for biomedical research...
‘GQ’ magazine’s global editorial director to discuss addiction and art at Vanderbilt Center for Addiction Research event April 21
Apr. 15, 2021—by Marissa Shapiro Apr. 13, 2021, 1:28 PM In recognition of Alcohol Awareness Month, the School of Medicine Basic Sciences will host a conversation between Will Welch, global editorial director of GQ magazine, and the Vanderbilt Center for Addiction Research on Wednesday, April 21, from 11 a.m. to noon CT. Registration is required. The virtual...
Evotec begins Phase I clinical trial of chikungunya antibody discovered by James Crowe, MD and VUMC colleagues
Feb. 5, 2021—A Vanderbilt University Medical Center licensee, Evotec SE, announced on January 28, 2020 that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development. The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of EVT894 vs placebo in healthy volunteers (five...